Expert Interviews: Chemistry, Manufacturing & Control
One of the most challenging steps in (nano)pharmaceutical development is the scale-up and reproducibility of the production process of nanomedicines.
To be able to achieve the industrial manufacturing stage of a nanomedicine, some hurdles need to be overcome:
- lack of batch-to-batch reproducibility during the process of manufacturing (i.e., passing from low-volumes needed at R&D level, to pilot scale and/or to industrial level),
- long-term stability of the products,
- the complexity of the manufacturing process and
- sterile conditions maintenance through the whole manufacturing process.
PHOENIX-OITB offers its customers GMP and non-GMP manufacturing and quality control for the development and manufacturing of nanoparticle formulations.
Alba Cordoba of NANOMOL Technologies describes the manufacturing and quality control services of the PHOENIX-OITB and their benefits for customers, as well as NANOMOL’s role in demo cases.
To access CMC services through a Single Entry Point, visit PHOENIX SEP.
